Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
38.69
+1.70 (4.60%)
At close: Jun 26, 2026, 4:00 PM EDT
38.40
-0.29 (-0.75%)
After-hours: Jun 26, 2026, 7:18 PM EDT
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Rigel Pharmaceuticals stock have an average target of 54, with a low estimate of 38 and a high estimate of 81. The average target predicts an increase of 39.57% from the current stock price of 38.69.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $57 | Buy | Reiterates | $57 | +47.32% | Jun 2, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $40 | Hold | Maintains | $40 | +3.39% | May 13, 2026 |
| Citi | Citi | Buy Reiterates $69 → $81 | Buy | Reiterates | $69 → $81 | +109.36% | May 13, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $38 | Hold | Maintains | $38 | -1.78% | Mar 4, 2026 |
Financial Forecast
Revenue This Year
276.60M
from 294.28M
Decreased by -6.01%
Revenue Next Year
330.90M
from 276.60M
Increased by 19.63%
EPS This Year
2.92
from 6.43
Decreased by -54.65%
EPS Next Year
4.78
from 2.92
Increased by 63.94%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 314.4M | 376.2M | |
| Avg | 276.6M | 330.9M | |
| Low | 216.3M | 306.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.8% | 36.0% | |
| Avg | -6.0% | 19.6% | |
| Low | -26.5% | 10.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.01 | 8.57 | |
| Avg | 2.92 | 4.78 | |
| Low | 0.64 | 2.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -37.6% | 193.9% | |
| Avg | -54.6% | 63.9% | |
| Low | -90.0% | -2.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.